Spiriva leads charge for Boehringer

pharmafile | April 23, 2009 | News story | Sales and Marketing |  Boehringer, COPD 

Related Content

Dupixent approved as first biologic medicine in Japan for COPD patients

The Ministry of Health, Labour and Welfare in Japan has authorised marketing and manufacturing of …

Verona Pharma to share phase 3 COPD trial data at ATS 2024

Verona Pharma has announced that it will share eight posters at the American Thoracic Society …

Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment

Sanofi and Regeneron have announced results from the second investigational phase 3 NOTUS trial for …

The Gateway to Local Adoption Series

Latest content